Partner with Ophelia for the most effective treatment for opioid use disorder

First nameLast nameTitleEmailPhone numberHow can we help?

By submitting your information you are opting-in to receive our newsletter with updates, educational content, and industry news.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form. Please try again.

For patients

How it works Insurance + pricing About Suboxone About buprenorphine FAQ Reviews Glossary Blog

Partner with us

Health insurers Health systems Refer a patient Research + insights Careers

Who we are

Our story Meet our team Press

Addiction is complicated. Our newsletter can help.

Thank you!

Something went wrong while submitting the form.

228 Park Ave S, Suite 15314 New York, NY 10003

Text us at (215) 585 2144

send faxes to (267) 780 7032
or email support@ophelia.com

Media inquiries: media@ophelia.com

This is not an emergency service. If this is an emergency, please leave this page and call 9-1-1 immediately.

Ophelia-affiliated physician group practices are independently owned and operated by licensed physicians who provide services utilizing the Ophelia telehealth platform.

Notice to California Residents: Ophelia Medical Group of CA, P.C., is a fictitious name for a California professional medical corporation pursuant to Cal. Bus. & Prof. Code § 2415. To view the Fictitious Name Permit click here.

Death Rate Maps & Graphs
Optum and OptumLabs Contribute to Major New Opioid Use Disorder Treatment Study
Perceived Relapse Risk and Desire for Medication Assisted Treatment among Persons Seeking Inpatient Opiate Detoxification